Mortality risk and temporal patterns of atrial fibrillation in the nationwide registry

被引:6
|
作者
Apiyasawat, Sirin [1 ]
Kornbongkotmas, Sakaorat [2 ]
Chichareon, Ply [3 ]
Krittayaphong, Rungroj [4 ]
机构
[1] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok, Thailand
[2] Queen Savang Vadhana Mem Hosp, Chon Buri, Thailand
[3] Prince Songkla Univ, Fac Med, Hat Yai, Thailand
[4] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok, Thailand
关键词
atrial fibrillation; atrial fibrillation type; mortality; registry; stroke; FOLLOW-UP; PERSISTENT; PROGRESSION; STROKE; DEFINITION; PROGNOSIS; WARFARIN; DEATH;
D O I
10.1002/joa3.12643
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Persistent and permanent atrial fibrillation (AF) often occurs in the presence of multiple comorbidities and is linked to adverse outcomes. It is unclear whether the sustained pattern of AF itself is prognostic or if it is confounded by underlying comorbidities. Here, we tested the association between the temporal patterns of AF and the risks of ischemic stroke and all-cause mortality. Methods and Results: In a prospective multicenter cohort, 3046 non-valvular AF patients were consecutively enrolled and followed for adverse outcomes of all-cause mortality and ischemic stroke. The risks of both outcomes were adjusted for underlying comorbidities, and compared between the patterns of AF. At baseline, the patients were classified as paroxysmal (N = 963, 31.6%), persistent (N = 604, 19.8%), and permanent AF (N = 1479, 45.6%) according to the standard definition. Anticoagulants were administered in 75% of all patients and 83% of those with CHA(2)DS(2)-VAS(c) score >= 2 in males or >= 3 in females. During a mean follow up of 26 (SD 10.5) months, all-cause mortality occurred less in paroxysmal AF (2.5 per 100 patient-years) than in persistent AF (4.4 per 100 patient-years; adjusted hazard ratio [HR] 0.66, 95% CI, 0.46-0.96; P = .029) and permanent AF (4.1 per 100 patient-years; adjusted HR 0.71, 95% CI, 0.52-0.98; P = .036). The risk of ischemic stroke was similar across all patterns of AF. Conclusions: In this multicenter cohort of AF patients, persistent and permanent AF was associated with higher all-cause mortality than paroxysmal AF, independent of baseline comorbidities. Clinical Trial Registration Thai Clinical Trial Registration; Study ID: TCTR20160113002 ().
引用
收藏
页码:1434 / 1442
页数:9
相关论文
共 50 条
  • [1] Atrial fibrillation and risk of venous thromboembolism: a Swedish Nationwide Registry Study
    Hornestam, Bjorn
    Adiels, Martin
    Giang, Kok Wai
    Hansson, Per-Olof
    Bjorck, Lena
    Rosengren, Annika
    [J]. EUROPACE, 2021, 23 (12): : 1913 - 1921
  • [2] Clinical Phenotypes of Atrial Fibrillation and Mortality Risk-A Cluster Analysis from the Nationwide Italian START Registry
    Pastori, Daniele
    Antonucci, Emilia
    Milanese, Alberto
    Menichelli, Danilo
    Palareti, Gualtiero
    Farcomeni, Alessio
    Pignatelli, Pasquale
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):
  • [3] Atrial fibrillation: A risk factor for increased mortality - An AVID registry analysis
    Wyse, DG
    Love, JC
    Yao, Q
    Carlson, MD
    Cassidy, P
    Greene, LH
    Martins, JB
    Ocampo, C
    Raitt, MH
    Schron, E
    Stamato, NJ
    Olarte, A
    [J]. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2001, 5 (03) : 267 - 273
  • [4] Atrial Fibrillation: A Risk Factor for Increased Mortality – An AVID Registry Analysis
    D. George Wyse
    John C. Love
    Qing Yao
    Mark D. Carlson
    Peggy Cassidy
    Leon H. Greene
    James B. Martins
    Celeste Ocampo
    Merritt H. Raitt
    Eleanor Schron
    Nicholas J. Stamato
    Anna Olarte
    [J]. Journal of Interventional Cardiac Electrophysiology, 2001, 5 : 267 - 273
  • [5] Atrial fibrillation and risk of pulmonary arterial hypertension. Swedisk nationwide registry study
    Hornestam, B.
    Giang, K. W.
    Bjork, L.
    Adiels, M.
    Rosengren, A.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 458 - 458
  • [6] Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation: results from the nationwide FinWAF Registry
    Lehto, Mika
    Niiranen, Jussi
    Korhonen, Pasi
    Mehtala, Juha
    Khanfir, Houssem
    Hoti, Fabian
    Lassila, Riitta
    Raatikainen, Pekka
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 (06) : 657 - 665
  • [7] Risk of mortality depends on the temporal sequence of atrial fibrillation and ischemic stroke
    Kwon, S.
    Kim, S.
    Bovik, A.
    Markey, M.
    Lee, H.
    Joo, G.
    Song, Y.
    Joung, B.
    Im, H.
    Park, J.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 862 - 862
  • [8] Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry
    Pastori, Daniele
    Antonucci, Emilia
    Violi, Francesco
    Palareti, Gualtiero
    Pignatelli, Pasquale
    Testa, Sophie
    Paoletti, Oriana
    Cosmi, Benilde
    Guazzaloca, Giuliana
    Migliaccio, Ludovica
    Poli, Daniela
    Marcucci, Rossella
    Maggini, Niccolo
    Pengo, Vittorio
    Falanga, Anna
    Lerede, Teresa
    Ruocco, Lucia
    Martini, Giuliana
    Pedrini, Simona
    Bertola, Federica
    Masciocco, Lucilla
    Saracino, Pasquale
    Benvenuto, Angelo
    Vasselli, Claudio
    Grandone, Elvira
    Colaizzo, Donatella
    Marzolo, Marco
    Pinelli, Mauro
    Mastroiacovo, Daniela
    Ageno, Walter
    Colombo, Giovanna
    Bucherini, Eugenio
    Serra, Domizio
    Toma, Andrea
    Barbera, Pietro
    Paparo, Carmelo
    Insana, Antonio
    Rupoli, Serena
    Malcangi, Giuseppe
    Zighetti, Maddalena Loredana
    Mangione, Catello
    Lione, Domenico
    Casasco, Paola
    Nante, Giovanni
    Tosetto, Alberto
    Oriana, Vincenzo
    Liberato, Nicola Lucio
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (21):
  • [9] Oral anticoagulation in atrial fibrillation patients at intermediate risk of stroke: a nationwide registry-based cohort (Atrial Fibrillation in Norway - AFNOR)
    Anjum, M.
    Ariansen, I.
    Hjellvik, V.
    Kjerpeseth, L. J.
    Selmer, R.
    Skovlund, E.
    Egeland, G. M.
    Christophersen, I. E.
    Myrstad, M.
    Tveit, A.
    Berge, T.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 473 - 473
  • [10] High overall cardiovascular risk and mortality in patients with atrial fibrillation and diabetes: A nationwide report
    Karayiannides, Stelios
    Lundman, Pia
    Friberg, Leif
    Norhammar, Anna
    [J]. DIABETES & VASCULAR DISEASE RESEARCH, 2018, 15 (01): : 31 - 38